On the other hand, in other reports low levels of α-SMA+ myofibroblasts correlated with poor survival of PC patients, thereby leading to the hypothesis that fibrosis constitutes a “protective” TME, rather than a tumor promoter. The gene discussed is ACTA1; the disease is pachyonychia congenita.